What medication is relatively safe to use during pregnancy among Pethidine, Danazol, Lithium, and Lisinopril?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pethidine is the Only Medication Relatively Safe to Use During Pregnancy Among the Listed Options

Among the medications listed (Pethidine, Danazol, Lithium, and Lisinopril), Pethidine is the only one that can be considered relatively safe for use during pregnancy when medically necessary.

Analysis of Each Medication

1. Pethidine (Meperidine)

  • Safety profile: While not completely without risk, Pethidine is used in obstetric practice for pain management during labor
  • FDA classification: Category C (risk cannot be ruled out, but potential benefits may justify the risk)
  • Can be used for short-term pain management during pregnancy when benefits outweigh risks
  • No evidence of major teratogenic effects in the available guidelines

2. Danazol

  • Absolutely contraindicated in pregnancy
  • Synthetic androgen with masculinizing effects on female fetuses
  • Can cause female pseudohermaphroditism and other genital abnormalities
  • High risk of virilization of female fetuses

3. Lithium

  • Strongly contraindicated in pregnancy
  • Associated with increased risk of cardiac malformations, particularly Ebstein's anomaly
  • Crosses the placenta freely and can cause neonatal toxicity
  • Risk of fetal cardiac defects, especially when used in the first trimester 1
  • Can cause neonatal lithium toxicity, including hypotonia, lethargy, and poor feeding

4. Lisinopril

  • Absolutely contraindicated in pregnancy
  • ACE inhibitors are known to cause fetal renal dysplasia, oligohydramnios, pulmonary hypoplasia, and intrauterine growth restriction 1
  • Associated with increased risk of fetal renal tubular dysplasia, oligohydramnios, growth retardation, and skull ossification disorders 1
  • Should be stopped as soon as pregnancy is detected 1

Clinical Considerations

Timing of Exposure

  • First trimester exposure to ACE inhibitors like Lisinopril may not be associated with congenital malformations, but second and third trimester exposure can cause significant fetopathy 1
  • Lithium exposure is most concerning in the first trimester due to risk of cardiac malformations
  • Danazol poses risks throughout pregnancy due to hormonal effects

Alternative Medications

  • For hypertension management in pregnancy, safer alternatives include methyldopa, nifedipine, and labetalol 1
  • For bipolar disorder, careful risk-benefit assessment is needed; some antipsychotics may have better safety profiles than lithium during pregnancy
  • For pain management, short-term use of Pethidine can be considered when necessary

Important Caveats

  • Even though Pethidine is the safest option among those listed, it should still be used with caution and only when clearly indicated
  • Prolonged use of Pethidine near delivery can cause neonatal respiratory depression
  • All medication use during pregnancy should involve careful consideration of maternal benefit versus fetal risk
  • Whenever possible, non-pharmacological approaches should be considered first

Clinical Algorithm for Medication Management in Pregnancy

  1. Immediately discontinue Danazol, Lithium, and Lisinopril upon confirmation of pregnancy
  2. For patients previously on Lisinopril, transition to a pregnancy-safe antihypertensive (methyldopa, labetalol, or nifedipine)
  3. For patients previously on Lithium, consult psychiatry for alternative management strategies
  4. For pain management requiring opioids, Pethidine can be used for short durations when benefits outweigh risks

Remember that while Pethidine is the safest option among these four medications, all medication use during pregnancy should be limited to situations where the maternal benefit clearly outweighs potential fetal risks.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.